Endowment Wealth Management, Inc.

Endowment

Position in CHRS — Coherus Oncology, Inc.

CIK 1904477 APPLETON, WI

Position in CHRS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$16,129

-$3,341 QoQ

Shares Held

11,521

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#107

of 145 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Endowment Wealth Management, Inc. holds $369,618 across 4 Biotechnology names. CHRS ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	4,793	$225,462
2	HUMA	Humacyte, Inc.	105,418	$82,226
3	RXRX	Recursion Pharmaceuticals, Inc.	12,480	$45,801
4	CHRS	Coherus Oncology, Inc. This page	11,521	$16,129

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,129	11,521	0.0%	Shares	Sole	2026-08-06
2026-03-31	$19,470	11,521	0.0%	Shares	Sole	2026-05-08
2025-12-31	$16,359	11,521	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.